• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植术后控制性低温保存对结局的影响。

Impact of controlled hypothermic preservation on outcomes following heart transplantation.

机构信息

Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, North Carolina.

出版信息

J Heart Lung Transplant. 2024 Jul;43(7):1153-1161. doi: 10.1016/j.healun.2024.03.010. Epub 2024 Mar 19.

DOI:10.1016/j.healun.2024.03.010
PMID:38503386
Abstract

BACKGROUND

Severe primary graft dysfunction (PGD) is a major cause of early mortality after heart transplant, but the impact of donor organ preservation conditions on severity of PGD and survival has not been well characterized.

METHODS

Data from US adult heart-transplant recipients in the Global Utilization and Registry Database for Improved Heart Preservation-Heart Registry (NCT04141605) were analyzed to quantify PGD severity, mortality, and associated risk factors. The independent contributions of organ preservation method (traditional ice storage vs controlled hypothermic preservation) and ischemic time were analyzed using propensity matching and logistic regression.

RESULTS

Among 1,061 US adult heart transplants performed between October 2015 and December 2022, controlled hypothermic preservation was associated with a significant reduction in the incidence of severe PGD compared to ice (6.6% [37/559] vs 10.4% [47/452], p = 0.039). Following propensity matching, severe PGD was reduced by 50% (6.0% [17/281] vs 12.1% [34/281], respectively; p = 0.018). The Kaplan-Meier terminal probability of 1-year mortality was 4.2% for recipients without PGD, 7.2% for mild or moderate PGD, and 32.1%, for severe PGD (p < 0.001). The probability of severe PGD increased for both cohorts with longer ischemic time, but donor hearts stored on ice were more likely to develop severe PGD at all ischemic times compared to controlled hypothermic preservation.

CONCLUSIONS

Severe PGD is the deadliest complication of heart transplantation and is associated with a 7.8-fold increase in probability of 1-year mortality. Controlled hypothermic preservation significantly attenuates the risk of severe PGD and is a simple yet highly effective tool for mitigating post-transplant morbidity.

摘要

背景

严重原发性移植物功能障碍(PGD)是心脏移植后早期死亡的主要原因,但供体器官保存条件对 PGD 严重程度和生存率的影响尚未得到很好的描述。

方法

分析了来自美国成人心脏移植受者的全球利用和登记数据库,以量化 PGD 严重程度、死亡率和相关风险因素。使用倾向匹配和逻辑回归分析器官保存方法(传统冰储存与控制性低温保存)和缺血时间的独立贡献。

结果

在 2015 年 10 月至 2022 年 12 月期间进行的 1061 例美国成人心脏移植中,与冰保存相比,控制性低温保存与严重 PGD 的发生率显著降低(6.6%[37/559] vs 10.4%[47/452],p=0.039)。在进行倾向匹配后,严重 PGD 降低了 50%(6.0%[17/281] vs 12.1%[34/281],p=0.018)。无 PGD 受者的 1 年死亡率的 Kaplan-Meier 终期概率为 4.2%,轻度或中度 PGD 为 7.2%,严重 PGD 为 32.1%(p<0.001)。缺血时间较长的两组发生严重 PGD 的概率均增加,但与控制性低温保存相比,冰保存的供心在所有缺血时间发生严重 PGD 的可能性更大。

结论

严重 PGD 是心脏移植最致命的并发症,与 1 年死亡率增加 7.8 倍相关。控制性低温保存可显著降低严重 PGD 的风险,是减轻移植后发病率的简单而有效的工具。

相似文献

1
Impact of controlled hypothermic preservation on outcomes following heart transplantation.心脏移植术后控制性低温保存对结局的影响。
J Heart Lung Transplant. 2024 Jul;43(7):1153-1161. doi: 10.1016/j.healun.2024.03.010. Epub 2024 Mar 19.
2
Early Outcomes of Primary Graft Dysfunction Comparing Donation After Circulatory and Brain Death Heart Transplantation: An Analysis of the UNOS Registry.比较心脏循环性死亡后捐献与脑死亡后捐献心脏移植的原发性移植物功能障碍早期结局:器官共享联合网络登记处分析
Clin Transplant. 2025 Jul;39(7):e70222. doi: 10.1111/ctr.70222.
3
Normothermic and hypothermic machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.常温及低温机器灌注保存与静态冷藏在尸体供肾移植中的比较。
Cochrane Database Syst Rev. 2024 Jul 9;7(7):CD011671. doi: 10.1002/14651858.CD011671.pub3.
4
Regional differences in primary graft dysfunction: A report from the international consortium on PGD.原发性移植功能障碍的区域差异:来自国际原发性移植功能障碍联盟的报告。
J Heart Lung Transplant. 2025 Jul;44(7):1052-1062. doi: 10.1016/j.healun.2025.02.1684. Epub 2025 Mar 6.
5
Recipient Outcomes With Extended Criteria Donors Using Advanced Heart Preservation: An Analysis of the GUARDIAN-Heart Registry.使用先进心脏保存技术的扩展标准供体受者结局:GUARDIAN-Heart注册研究分析
J Heart Lung Transplant. 2024 Apr;43(4):673-680. doi: 10.1016/j.healun.2023.12.013. Epub 2023 Dec 30.
6
Predictors and outcomes of severe primary graft dysfunction in heart transplantation: United States cohort analysis.心脏移植中严重原发性移植物功能障碍的预测因素及结局:美国队列分析
J Heart Lung Transplant. 2025 Aug 20. doi: 10.1016/j.healun.2025.07.036.
7
Donor History of Drug Use and Graft Survival in Pediatric Heart Transplant Recipients.小儿心脏移植受者的供体药物使用史与移植物存活情况
JAMA Netw Open. 2025 Apr 1;8(4):e257766. doi: 10.1001/jamanetworkopen.2025.7766.
8
Post-transplant survival after normothermic regional perfusion versus direct procurement and perfusion in donation after circulatory determination of death in heart transplantation.在心跳骤停后循环判定死亡的供体器官捐献中,常温区域性灌注与直接获取和灌注相比的移植后存活率。
J Heart Lung Transplant. 2024 Jun;43(6):954-962. doi: 10.1016/j.healun.2024.02.1456. Epub 2024 Feb 27.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
A New Era of Decision Making in Liver Transplantation: A Prospective Validation and Cost-Effectiveness Analysis of FMN-Guided Liver Viability Assessment During Normothermic Machine Perfusion.肝移植决策的新时代:常温机器灌注期间FMN引导的肝活力评估的前瞻性验证及成本效益分析
Ann Surg. 2025 Jul 21. doi: 10.1097/SLA.0000000000006822.

引用本文的文献

1
Expanding the Donor Pool.扩大供体库。
Methodist Debakey Cardiovasc J. 2025 May 15;21(3):33-39. doi: 10.14797/mdcvj.1577. eCollection 2025.
2
Cardiac preservation using organ perfusion: new therapies for the treatment of heart failure by harnessing the power of growth factors using BMP mimetics like THR-184.使用器官灌注进行心脏保存:通过利用如THR-184等BMP模拟物的生长因子力量来治疗心力衰竭的新疗法。
Front Cardiovasc Med. 2025 Mar 18;12:1535778. doi: 10.3389/fcvm.2025.1535778. eCollection 2025.
3
Clinical Outcomes of Machine Perfusion and Temperature Control Systems in Heart Transplantation: Where We Stand.
心脏移植中机器灌注和温度控制系统的临床结果:我们的现状
J Clin Med. 2025 Feb 11;14(4):1152. doi: 10.3390/jcm14041152.
4
Moderate controlled hypothermia standard ice-cold storage of cardiac allografts to expand the donor pool: insights from the GUARDIAN registry.适度控制性低温联合心脏同种异体移植物标准冷藏以扩大供体库:来自GUARDIAN注册研究的见解
Ann Cardiothorac Surg. 2025 Jan 26;14(1):28-36. doi: 10.21037/acs-2024-dcd-21. Epub 2024 Dec 11.
5
Chilling Choices: Heart Transplant Outcomes Using SherpaPak With Long Ischemic Time Versus Traditional Ice Storage With Short Ischemic Time.寒冷选择:使用SherpaPak进行长缺血时间心脏移植的结果与使用传统冰储存进行短缺血时间心脏移植的结果对比
ASAIO J. 2025 Apr 1;71(4):308-315. doi: 10.1097/MAT.0000000000002357. Epub 2024 Dec 12.
6
Risk factors and prognostic modeling in bridging extracorporeal membrane oxygenation patients before lung transplantation.肺移植前体外膜肺氧合桥接患者的危险因素及预后模型
J Thorac Dis. 2024 Aug 31;16(8):5238-5247. doi: 10.21037/jtd-24-430. Epub 2024 Aug 23.
7
Revolutionizing Donor Heart Procurement: Innovations and Future Directions for Enhanced Transplantation Outcomes.革新供体心脏获取:改善移植结果的创新与未来方向
J Cardiovasc Dev Dis. 2024 Jul 27;11(8):235. doi: 10.3390/jcdd11080235.
8
Primary graft dysfunction in heart transplantation: the challenge to survival.心脏移植中的原发性移植物功能障碍:对生存的挑战。
J Cardiothorac Surg. 2024 Jun 1;19(1):313. doi: 10.1186/s13019-024-02816-6.
9
Cold precision: Enhancing organ preservation with controlled hypothermia.低温精准性:通过控制性低温增强器官保存效果。
J Heart Lung Transplant. 2024 Sep;43(9):1527-1528. doi: 10.1016/j.healun.2024.05.002. Epub 2024 May 15.
10
Special Considerations for Advanced Heart Failure Surgeries: Durable Left Ventricular Devices and Heart Transplantation.晚期心力衰竭手术的特殊考虑因素:耐用左心室装置与心脏移植
J Cardiovasc Dev Dis. 2024 Apr 15;11(4):119. doi: 10.3390/jcdd11040119.